Through effective partnering and cross-licensing, DowDuPont has established itself as a leader in agricultural genome editing

May 22, 2018 | Case Study

DowDuPont has a successful business as an industry leader in agrichemicals and transgenic crop trait innovation. Since 2015, the company has been taking significant, strategic steps to establish a dominant presence in the field of crop trait development through genome editing, focusing on the CRISPR system to do so. DowDuPont's IP portfolio, built through a series of in-licensing and cross-licensing agreements, is the most robust in the agriculture industry for crop trait development and has led to the development of additional improvements in the functionality of CRISPR systems, including the ability to map off-target activity, which has been a key concern for the future safety of CRISPR applications in both crops and human health.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978